Filing Details
- Accession Number:
- 0000898432-25-000342
- Form Type:
- 13G Filing
- Publication Date:
- 2025-05-13 20:00:00
- Filed By:
- Akram Mahesh
- Company:
- Amneal Pharmaceuticals Inc. (NYSE:AMRX)
- Filing Date:
- 2025-05-14
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Beneficially Owned Number of Shares | Beneficially Owned Number of Aggregate Shares | Percent of Class |
|---|---|---|---|
| Akram Mahesh | 0 | 20,558,759 | 6.56% |
Filing
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment No. 2)
|
Amneal Pharmaceuticals, Inc. (Name of Issuer) |
Class A Common Stock, par value $0.01 (Title of Class of Securities) |
03168L105 (CUSIP Number) |
03/31/2025 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule 13d-1(b)
|
 Rule 13d-1(c)
|
| Rule 13d-1(d)
|
SCHEDULE 13G
|
| CUSIP No. | 03168L105 |
| 1 | Names of Reporting Persons
Akram Mahesh | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
20,558,759.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
6.56 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person: 1. Number of shares is number of Class A Common Stock, par value $0.01 per share ("Class A Common Stock") of Amneal Pharmaceuticals, Inc. (the "Issuer").
2. The percentage of ownership of the Class A Common Stock by the Reporting Person presented in this Statement is based on 313,419,599 shares of Class A Common Stock outstanding, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed on May 7, 2025.
SCHEDULE 13G
|
| Item 1. | ||
| (a) | Name of issuer:
Amneal Pharmaceuticals, Inc. | |
| (b) | Address of issuer's principal executive offices:
400 Crossing Blvd, Bridgewater, New Jersey, 08807 | |
| Item 2. | ||
| (a) | Name of person filing:
Akram Mahesh | |
| (b) | Address or principal business office or, if none, residence:
c/o Tattva Fiduciary Company
100 West Liberty Street, 10th Floor
Reno, NV 89501 | |
| (c) | Citizenship:
United States | |
| (d) | Title of class of securities:
Class A Common Stock, par value $0.01 | |
| (e) | CUSIP No.:
03168L105 | |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
| (a) | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
| |
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
| |
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
| |
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
| |
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
| |
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
| |
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
| |
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
| |
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
| |
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution: | |
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
| |
| Item 4. | Ownership | |
| (a) | Amount beneficially owned:
See Item 9 of the cover pages to this Schedule 13G for the aggregate number of Class A Common Stock that are beneficially owned by the Reporting Person as of March 31, 2025. | |
| (b) | Percent of class:
See Item 11 of the cover pages to this Schedule 13G for the percentage of Class A Common Stock that are beneficially owned by the Reporting Person as of March 31, 2025. | |
| (c) | Number of shares as to which the person has:
| |
| (i) Sole power to vote or to direct the vote:
See Items 5 through 8 of the cover pages to this Schedule 13G for the number of Class A Common Stock that are beneficially owned by the Reporting Person as of March 31, 2025 as to which there is sole or shared power to vote or direct the vote, and sole or shared power to dispose or direct the disposition. | ||
| (ii) Shared power to vote or to direct the vote:
| ||
| (iii) Sole power to dispose or to direct the disposition of:
| ||
| (iv) Shared power to dispose or to direct the disposition of:
| ||
| Item 5. | Ownership of 5 Percent or Less of a Class. | |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
This Schedule 13G is filed solely to report the Reporting Person's deemed beneficial ownership of the shares of Class A Common Stock of the Issuer held by certain trusts (the "Trusts") of which Tattva Fiduciary Company ("Tattva") is the sole trustee. The Reporting Person is the sole owner of Tattva. The Reporting Person does not otherwise have beneficial ownership of any shares of Class A Common Stock of the Issuer. Each Trust may have the right to receive dividends from, or the proceeds from the sale of, the shares of Class A Common Stock that are held by such Trust. No individual Trust has an interest in any shares of Class A Common Stock that relates to more than five percent of the outstanding Class A Common Stock. | ||
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
| Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
| Item 9. | Notice of Dissolution of Group. | |
Not Applicable
| ||
| Item 10. | Certifications: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|